Search

everythinglearnresearchcommunity

for

Search:↓

Male and female hair loss have different genetic causes.

Long-term healthy eating lowers testosterone and improves health in women with suspected PCOS.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Adult acne is often mild and common on the cheek, with a low prevalence of PCOS in female patients, but more severe acne and skin damage in those with PCOS.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Hormone levels studied are not linked to PCOS.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Prenatal pesticide exposure may cause earlier breast development in girls.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Helping PCOS patients focus on hope and control can reduce depression.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

BMI is not enough for assessing obesity in women; use more personalized tools.

Healthcare providers in Addis Ababa need better education and training for diagnosing PCOS.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Classical PCOS types A and B are most common and linked to higher health risks.